TY - JOUR
T1 - Newborn screening
T2 - Rationale for a comprehensive, fully integrated public health system
AU - McCabe, Linda L.
AU - Therrell, Bradford L.
AU - McCabe, Edward R.B.
N1 - Copyright:
Copyright 2019 Elsevier B.V., All rights reserved.
PY - 2002
Y1 - 2002
N2 - Newborn screening has existed for approximately four decades [1]. During that period of time, newborn screening has evolved conceptually from a laboratory test for a single disorder, phenylketonuria (PKU), to a multi-part public health system involving education, screening, diagnostic follow-up, treatment/management, and system evaluation [2-5]. At a time when newborn screening is recognized as a model for predictive medicine [6,7], it also faces critical challenges that will determine its future credibility and viability. In order to understand these challenges, it is helpful to review briefly the history of newborn screening.
AB - Newborn screening has existed for approximately four decades [1]. During that period of time, newborn screening has evolved conceptually from a laboratory test for a single disorder, phenylketonuria (PKU), to a multi-part public health system involving education, screening, diagnostic follow-up, treatment/management, and system evaluation [2-5]. At a time when newborn screening is recognized as a model for predictive medicine [6,7], it also faces critical challenges that will determine its future credibility and viability. In order to understand these challenges, it is helpful to review briefly the history of newborn screening.
UR - http://www.scopus.com/inward/record.url?scp=12244300531&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=12244300531&partnerID=8YFLogxK
U2 - 10.1016/S1096-7192(02)00196-8
DO - 10.1016/S1096-7192(02)00196-8
M3 - Article
C2 - 12468271
AN - SCOPUS:12244300531
VL - 77
SP - 267
EP - 273
JO - Biochemical Medicine and Metabolic Biology
JF - Biochemical Medicine and Metabolic Biology
SN - 1096-7192
IS - 4
ER -